Capable and Intuitive Delivery
The delivery system allows for stable, precise implant placement, with the ability to reposition to optimize results
Versa Vascular is leading development of a novel tricuspid valve repair solution in Santa Cruz, California
In the United States, it is estimated that 1.6 million individuals have clinically relevant tricuspid regurgitation. Surgical intervention in these patients is frequently associated with early and late mortality. Versa Vascular is developing a minimally invasive treatment option that can help a wide range of patients with severe tricuspid regurgitation, helping them lead longer, healthier lives.
The delivery system allows for stable, precise implant placement, with the ability to reposition to optimize results
The implant sits entirely in the right atrium with a low radial force, avoiding interactions with sub-valvular apparatus
The Versa Implant works with native leaflet function to improve blood flow through the tricuspid valve